Fig. 2From: miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancerThe expression status of miR-17-5p in clinical TNBC samples detected by In situ hybridization. a, c, Negative control of miR-17-5p in TNBC and adjacent non-tumour tissues. Positive expression of miR-17-5p in TNBC (d, e) and non-tumour tissues (b) was also presented. Scale bar, 10 μmBack to article page